Showing results (111-120 of 256) with videos related to

Sort By:
Pageof 26
Iscience|January 10, 2022
Salivary ZG16B expression loss follows exocrine gland dysfunction related to oral chronic graft-versus-host diseaseAna Caroline Costa-da-Silva, Marit H Aure, Joshua Dodge, et al.
Bone Marrow Transplantation|September 8, 2023
Metabolic syndrome prevalence and impact on outcomes in patients with chronic graft-versus-host diseaseAaron T Zhao, Filip Pirsl, Seth M Steinberg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 1, 2010
Salivary gland involvement in chronic graft-versus-host disease: prevalence, clinical significance, and recommendations for evaluationMatin M Imanguli, Jane C Atkinson, Sandra A Mitchell, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 22, 2006
Ex vivo rapamycin generates Th1/Tc1 or Th2/Tc2 Effector T cells with enhanced in vivo function and differential sensitivity to post-transplant rapamycin therapyUnsu Jung, Jason E Foley, Andreas A Erdmann, et al.
Journal of Translational Medicine|September 17, 2014
Counter-flow elutriation of clinical peripheral blood mononuclear cell concentrates for the production of dendritic and T cell therapiesDavid F Stroncek, Vicki Fellowes, Chauha Pham, et al.
Bone Marrow Transplantation|July 20, 2023
Predictors and significance of kidney dysfunction in patients with chronic graft-versus-host diseaseDavid Beshensky, Filip Pirsl, Noa G Holtzman, et al.
Autophagy|May 2, 2013
Harnessing autophagy for cell fate control gene therapyTania C Felizardo, Jason Foley, Kevin Steed, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 27, 2009
Assessment of the hematopoietic cell transplantation comorbidity index in non-Hodgkin lymphoma patients receiving reduced-intensity allogeneic hematopoietic stem cell transplantationSeth M Pollack, Seth M Steinberg, Jeanne Odom, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2015
High-Dose Sirolimus and Immune-Selective Pentostatin plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-versus-Tumor ResponsesMiriam E Mossoba, David C Halverson, Roger Kurlander, et al.
Pageof 26